This review highlights the role of molecular mimicry and postinfectious autoimmunity in the pathogenesis of chronic Chagas disease cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Does not alter Chagas cardiomyopathy management; leaves open need for trials targeting molecular mimicry.
Up to 18 million of individuals are infected by the protozoan parasite Trypanosoma cruzi in Latin America, one third of whom will develop chronic Chagas disease cardiomyopathy (CCC) up to 30 years after infection. Cardiomyocyte destruction is associated with a T cell-rich inflammatory infiltrate and fibrosis. The presence of such lesions in the relative scarcity of parasites in the heart, suggested that CCC might be due, in part, to a postinfectious autoimmune process. Over the last two decades, a significant amount of reports of autoimmune and molecular mimicry phenomena have been described in CCC. The authors will review the evidence in support of an autoimmune basis for CCC pathogenesis in humans and experimental animals, with a special emphasis on molecular mimicry as a fundamental mechanism of autoimmunity.
No takes yet. Share an insight, caveat, or question.
Cunha‐Neto et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: